CHARLES SCHWAB INVESTMENT MANAGEMENT INC - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 87 filers reported holding FORTRESS BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q2 2023$16,481
-32.9%
29,9650.0%0.00%
Q1 2023$24,571
+25.2%
29,9650.0%0.00%
Q4 2022$19,627
-24.5%
29,9650.0%0.00%
Q3 2022$26,0000.0%29,9650.0%0.00%
Q2 2022$26,000
-90.4%
29,965
-85.0%
0.00%
Q1 2022$272,000
-41.8%
199,473
+7.0%
0.00%
Q4 2021$467,000
-22.3%
186,5070.0%0.00%
Q3 2021$601,000
-5.4%
186,507
+4.9%
0.00%
Q2 2021$635,000
+5.3%
177,724
+4.2%
0.00%
Q1 2021$603,000
+11.7%
170,616
+0.3%
0.00%
Q4 2020$540,000
-16.7%
170,102
+6.2%
0.00%
Q3 2020$648,000
+55.8%
160,182
+3.2%
0.00%
Q2 2020$416,000
+208.1%
155,178
+105.1%
0.00%
Q1 2019$135,000
+175.5%
75,653
+33.0%
0.00%
Q4 2018$49,000
-46.7%
56,9000.0%0.00%
Q3 2018$92,000
-45.9%
56,9000.0%0.00%
Q2 2018$170,000
-34.4%
56,9000.0%0.00%
Q1 2018$259,000
+13.6%
56,9000.0%0.00%
Q4 2017$228,000
-9.5%
56,9000.0%0.00%
Q3 2017$252,000
-7.0%
56,9000.0%0.00%
Q2 2017$271,000
+28.4%
56,9000.0%0.00%
Q1 2017$211,000
+37.0%
56,9000.0%0.00%
Q4 2016$154,000
-8.9%
56,9000.0%0.00%
Q3 2016$169,000
+9.7%
56,9000.0%0.00%
Q2 2016$154,00056,9000.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,000,000$580,6000.19%
Nantahala Capital Management 6,018,211$1,747,0870.15%
THOMPSON DAVIS & CO., INC. 12,996$3,7730.01%
Platform Technology Partners 30,000$8,7090.00%
Black Maple Capital Management LP 15,000$4,3550.00%
Arete Wealth Advisors, LLC 52,547$15,2540.00%
B. Riley Wealth Advisors, Inc. 144,700$42,0060.00%
ACADIAN ASSET MANAGEMENT LLC 1,075,531$3110.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 1,542,000$447,6430.00%
GROUP ONE TRADING, L.P. 2,000$5810.00%
View complete list of FORTRESS BIOTECH INC shareholders